NCT05395156

Brief Summary

These will be no effect of transcutaneous electrical acupoint stimulation on premenstrual syndrome Does transcutaneous electrical acupoint stimulation affect premenstrual syndrome (PMS)?

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2022

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 24, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 27, 2022

Completed
14 days until next milestone

Study Start

First participant enrolled

June 10, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 10, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 10, 2022

Completed
Last Updated

May 27, 2022

Status Verified

May 1, 2022

Enrollment Period

3 months

First QC Date

May 24, 2022

Last Update Submit

May 24, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • pain severity

    The pain intensity will be assessed through visual analogue scale (VAS) for each participant in both groups before and after treatment Each participant will be asked to mark a point on VAS line between the extremes that related to her current pain intensity

    Up to 3 monthes

  • premenstrual syndrome severity

    Participants can differentiate between their experiences of different symptoms during menstrual cycle and they will be assessed before and after treatment using the Menstrual Distress Questionnaire (MDQ) Each participant will be asked to rate their experience of each of the symptoms on the MDQ on a scale ranging from no experience of the symptom to an acute or partially disabling experience of the symptom

    up to 3 monthes

Study Arms (2)

sham acupoint

EXPERIMENTAL

Control group: (placebo group) will be consisted of twenty-five females diagnosed with premenstrual syndrome. They will receive TEAS on sham acupoint (the acupoint selection site was 1 inch away from the acupoint selection in the study group) daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles with average of 7 sessions per month for 3 months

Device: Transcutaneous electrical nerve stimulation (TENS)

Electroacupuncture

EXPERIMENTAL

Study group: (Electroacupuncture group) will be consisted of twenty-five females diagnosed with premenstrual syndrome. They will receive TEAS on neurogenic acupoints daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles with average of 7 sessions per month for 3 months.

Device: Transcutaneous electrical nerve stimulation (TENS)

Interventions

Control group will receive TEAS on sham acupoint daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles Study group will receive TEAS on neurogenic acupoints daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles

Electroacupuncturesham acupoint

Eligibility Criteria

Age18 Years - 25 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Their age will range from 18 to 25 years.
  • The regularity of menstrual cycle is 28-35 days.
  • All of them suffering from moderate and sever PMS.
  • All participants are virgin.
  • Their BMI will range from 25-30 kg\\m2.

You may not qualify if:

  • Any pathological findings in the pelvic cavity as PCO, Endometriosis and pelvic inflammatory disease.
  • Any history of gynecological intervention.
  • Have any condition impedes the use of electrotherapy.
  • Receiving sedatives or any medical treatment.
  • Having irregular menstruation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Transcutaneous Electric Nerve Stimulation

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Central Study Contacts

Azza Barmoud, professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
spicialist of physical therapy at talkha central hospital

Study Record Dates

First Submitted

May 24, 2022

First Posted

May 27, 2022

Study Start

June 10, 2022

Primary Completion

September 10, 2022

Study Completion

October 10, 2022

Last Updated

May 27, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL, SAP, ICF